PlainPharmaWatch

CMS Open Payments · Program Year 2024

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. reported $1,721,708.57 in payments to 27,251 physicians and teaching hospitals across 27,347 transactions.

See the rankings → How this is sourced
$1.7M
Total payments
27,347
Transactions
27,251
Recipients
+$810.1K
General Payments vs PY2023

Esperion Therapeutics, Inc. reported $1,721,708.57 in payments to 27,251 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #487 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $63.18 per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Esperion Therapeutics, Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#487
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Esperion Therapeutics, Inc.'s CMS-reported General Payments increased by $810.1K (+160.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ESPERION THERAPEUTICS, INC.PY2023: ESPERION THERAPEUTICS, INC.PY2024: Esperion Therapeutics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$505.1KPY2024$1.3M
PY2023
$505,088.15
PY2024
$1,315,184.82

How Esperion Therapeutics, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Esperion Therapeutics, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,721,709 Top 25% higher than 75% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Esperion Therapeutics, Inc.

$1,721,708.57: that is what Esperion Therapeutics, Inc. reported in payments to 27,251 physicians and teaching hospitals during Program Year 2024, spread across 27,347 transactions ($62.96 per transaction, $63.18 per recipient). The company sits at rank #487 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $563.7K, accounting for 32.7% of the company's reported total and 26,747 transactions.

General Payment Breakdown by Type

Across 6 types of general payments, Esperion Therapeutics, Inc.'s largest category was "Food and Beverage" at $563.7K - 32.7% of the company's reported total.

How Esperion Therapeutics, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$563.7K2. Compensation for Services…$544.8K3. Travel and Lodging$136.0K4. Consulting Fee$69.3K5. Honoraria$1.1K6. Education$250.00
Payment Type Amount Transactions
Food and Beverage $563.7K 26,747
Compensation for Services Other Than Consulting $544.8K 199
Travel and Lodging $136.0K 266
Consulting Fee $69.3K 33
Honoraria $1.1K 1
Education $250.00 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $241,618.23 (18.4%) of $1,315,184.82 in this company's General Payments records across 13,430 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Esperion Therapeutics, Inc.

The five named recipients with the highest reported General Payments from this company

Payal Kohli$79.1KJohn Isaac$50.4KMatthew Budoff$43.0KNarendra Singh$37.1KJAMES Adam UNDERBERG$32.0K
  1. 1

    Payal Kohli

    $79,090.61 across 63 reported transactions

  2. 2

    John Isaac

    $50,448.57 across 54 reported transactions

  3. 3

    Matthew Budoff

    $42,983.81 across 34 reported transactions

  4. 4

    Narendra Singh

    $37,121.85 across 39 reported transactions

  5. 5

    JAMES Adam UNDERBERG

    $31,973.39 across 35 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $62.96. Average per recipient: $63.18.

Total Amount

$1,721,708.57

Avg per Transaction

$62.96

Avg per Recipient

$63.18

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Esperion Therapeutics, Inc. Share

0.0%

#487 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Esperion Therapeutics, Inc.

Pharmacosmos Therapeutics Inc.

$1.7M 7,020 recipients

Y-mAbs Therapeutics, Inc.

$1.7M 159 recipients

bioMerieux Inc

$1.7M 600 recipients

Dompe US, Inc.

$1.7M 11,308 recipients

Radiometer America, Inc

$1.7M 84 recipients

Shionogi Inc

$1.7M 5,823 recipients

Frequently Asked Questions

How much did Esperion Therapeutics, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,721,708.57 from Esperion Therapeutics, Inc. to physicians and hospitals across 27,347 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Esperion Therapeutics, Inc.? ▾
Averaging $63.18 per recipient, Esperion Therapeutics, Inc.'s 2024 payments reached 27,251 physicians and teaching hospitals.
What types of payments did Esperion Therapeutics, Inc. make? ▾
General payments from Esperion Therapeutics, Inc. span 6 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $563.7K, representing 32.7% of the company's reported total.
How does Esperion Therapeutics, Inc. rank among pharmaceutical companies? ▾
Esperion Therapeutics, Inc. ranks #487 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Esperion Therapeutics, Inc.? ▾
Esperion Therapeutics, Inc.'s 27,347 transactions to 27,251 recipients in 2024 averaged $62.96 per transaction.
Where does the payment data for Esperion Therapeutics, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Esperion Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.